标题
Glutamate and dopamine in schizophrenia: An update for the 21st century
作者
关键词
-
出版物
JOURNAL OF PSYCHOPHARMACOLOGY
Volume 29, Issue 2, Pages 97-115
出版商
SAGE Publications
发表日期
2015-01-14
DOI
10.1177/0269881114563634
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A neurobiological hypothesis for the classification of schizophrenia: type a (hyperdopaminergic) and type B (normodopaminergic)
- (2014) Oliver D. Howes et al. BRITISH JOURNAL OF PSYCHIATRY
- Alterations in cortical and extrastriatal subcortical dopamine function in schizophrenia: systematic review and meta-analysis of imaging studies
- (2014) Joseph Kambeitz et al. BRITISH JOURNAL OF PSYCHIATRY
- Schizophrenia: from dopaminergic to glutamatergic interventions
- (2014) Marc Laruelle CURRENT OPINION IN PHARMACOLOGY
- A phase II/III trial of bitopertin monotherapy compared with placebo in patients with an acute exacerbation of schizophrenia – Results from the CandleLyte study
- (2014) D. Bugarski-Kirola et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Initial Evaluation of 18F-GE-179, a Putative PET Tracer for Activated N-Methyl D-Aspartate Receptors
- (2014) C. J. McGinnity et al. JOURNAL OF NUCLEAR MEDICINE
- Stress-Induced Dopamine Response in Subjects at Clinical High Risk for Schizophrenia with and without Concurrent Cannabis Use
- (2014) Romina Mizrahi et al. NEUROPSYCHOPHARMACOLOGY
- Alterations in the serotonin system in schizophrenia: A systematic review and meta-analysis of postmortem and molecular imaging studies
- (2014) Sudhakar Selvaraj et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Glutamatergic abnormalities in schizophrenia: A review of proton MRS findings
- (2014) Eline M.P. Poels et al. SCHIZOPHRENIA RESEARCH
- Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: A double blind, randomized, controlled trial
- (2014) Fang Liu et al. SCHIZOPHRENIA RESEARCH
- Dopaminergic basis of salience dysregulation in psychosis
- (2014) Toby T. Winton-Brown et al. TRENDS IN NEUROSCIENCES
- Increased Glutamine in Patients Undergoing Long-term Treatment for Schizophrenia
- (2014) Juan R. Bustillo et al. JAMA Psychiatry
- Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia
- (2013) Arsime Demjaha et al. AMERICAN JOURNAL OF PSYCHIATRY
- Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort
- (2013) Alice Egerton et al. BIOLOGICAL PSYCHIATRY
- Antipsychotic Treatment Resistance in Schizophrenia Associated with Elevated Glutamate Levels but Normal Dopamine Function
- (2013) Arsime Demjaha et al. BIOLOGICAL PSYCHIATRY
- Dopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms
- (2013) Michael A.P. Bloomfield et al. BIOLOGICAL PSYCHIATRY
- Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study
- (2013) Oliver D. Howes et al. BRAIN
- Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task
- (2013) Ivonne Suridjan et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: Possible involvement of antioxidant and nitrergic pathways
- (2013) Aline Santos Monte et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
- (2013) Harvey A Whiteford et al. LANCET
- Imaging dopamine transmission in the frontal cortex: a simultaneous microdialysis and [11C]FLB 457 PET study
- (2013) R Narendran et al. MOLECULAR PSYCHIATRY
- Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders and associations with SNPs in postmortem brain
- (2013) S S Kaalund et al. MOLECULAR PSYCHIATRY
- Imaging Patients with Psychosis and a Mouse Model Establishes a Spreading Pattern of Hippocampal Dysfunction and Implicates Glutamate as a Driver
- (2013) Scott A. Schobel et al. NEURON
- Acute Shift in Glutamate Concentrations Following Experimentally Induced Panic with Cholecystokinin Tetrapeptide—A 3T-MRS Study in Healthy Subjects
- (2013) Peter Zwanzger et al. NEUROPSYCHOPHARMACOLOGY
- Proton magnetic resonance spectroscopy measures related to short-term symptomatic outcome in chronic schizophrenia
- (2013) Agata Szulc et al. NEUROSCIENCE LETTERS
- Glutamate, N-acetyl aspartate and psychotic symptoms in chronic ketamine users
- (2013) James M. Stone et al. PSYCHOPHARMACOLOGY
- Reduced Frontal Glutamate + Glutamine and N-Acetylaspartate Levels in Patients With Chronic Schizophrenia but not in Those at Clinical High Risk for Psychosis or With First-Episode Schizophrenia
- (2013) Tatsunobu Natsubori et al. SCHIZOPHRENIA BULLETIN
- Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy
- (2013) Neeraj Tandon et al. SCHIZOPHRENIA RESEARCH
- Rapid Improvement of Acute Schizophrenia Symptoms After Intravenous Sodium Nitroprusside
- (2013) Jaime E. C. Hallak et al. JAMA Psychiatry
- Glutamate Levels in the Associative Striatum Before and After 4 Weeks of Antipsychotic Treatment in First-Episode Psychosis
- (2013) Camilo de la Fuente-Sandoval et al. JAMA Psychiatry
- The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
- (2012) Oliver D. Howes et al. ARCHIVES OF GENERAL PSYCHIATRY
- Increased Stress-Induced Dopamine Release in Psychosis
- (2012) Romina Mizrahi et al. BIOLOGICAL PSYCHIATRY
- Alterations of the Brain Reward System in Antipsychotic Naïve Schizophrenia Patients
- (2012) Mette Ødegaard Nielsen et al. BIOLOGICAL PSYCHIATRY
- Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation
- (2012) Oliver D. Howes et al. BRITISH JOURNAL OF PSYCHIATRY
- Sustained NMDA Receptor Hypofunction Induces Compromised Neural Systems Integration and Schizophrenia-Like Alterations in Functional Brain Networks
- (2012) Neil Dawson et al. CEREBRAL CORTEX
- Recent Advances in Targeting the Ionotropic Glutamate Receptors in Treating Schizophrenia
- (2012) Robert E. McCullumsmith et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- From the Prodrome to Chronic Schizophrenia: The Neurobiology Underlying Psychotic Symptoms and Cognitive Impairments
- (2012) O. D. Howes et al. CURRENT PHARMACEUTICAL DESIGN
- PET and SPECT tracers for glutamate receptors
- (2012) Vattoly J. Majo et al. DRUG DISCOVERY TODAY
- Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosis
- (2012) Oswald J.N. Bloemen et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Vulnerability to psychotogenic effects of ketamine is associated with elevated D2/3-receptor availability
- (2012) Ingo Vernaleken et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A Multicenter, Add-On Randomized Controlled Trial of Low-Dosed-Serine for Negative and Cognitive Symptoms of Schizophrenia
- (2012) Mark Weiser et al. JOURNAL OF CLINICAL PSYCHIATRY
- Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment
- (2012) Imran B Chaudhry et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Striatal dopamine release in schizophrenia comorbid with substance dependence
- (2012) J L Thompson et al. MOLECULAR PSYCHIATRY
- Subchronic ketamine treatment leads to permanent changes in EEG, cognition and the astrocytic glutamate transporter EAAT2 in mice
- (2012) Robert E. Featherstone et al. NEUROBIOLOGY OF DISEASE
- Nature or Nurture? Determining the Heritability of Human Striatal Dopamine Function: an [18F]-DOPA PET Study
- (2012) Paul R A Stokes et al. NEUROPSYCHOPHARMACOLOGY
- Dissociation of Hedonic Reaction to Reward and Incentive Motivation in an Animal Model of the Negative Symptoms of Schizophrenia
- (2012) Ryan D Ward et al. NEUROPSYCHOPHARMACOLOGY
- Anterior Cingulate Glutamate Levels Related to Clinical Status Following Treatment in First-Episode Schizophrenia
- (2012) Alice Egerton et al. NEUROPSYCHOPHARMACOLOGY
- Dopaminergic Neurotransmission in Patients with Schizophrenia in Relation to Positive and Negative Symptoms
- (2012) O. Pogarell et al. PHARMACOPSYCHIATRY
- The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory
- (2012) Euitae Kim et al. PSYCHOPHARMACOLOGY
- The role of glutamatergic inputs onto parvalbumin-positive interneurons: relevance for schizophrenia
- (2012) Diana C. Rotaru et al. REVIEWS IN THE NEUROSCIENCES
- Dopaminergic Function in the Psychosis Spectrum: An [18F]-DOPA Imaging Study in Healthy Individuals With Auditory Hallucinations
- (2012) Oliver D. Howes et al. SCHIZOPHRENIA BULLETIN
- Neural and Behavioral Correlates of Aberrant Salience in Individuals at Risk for Psychosis
- (2012) Jonathan P. Roiser et al. SCHIZOPHRENIA BULLETIN
- Transition to Psychosis Associated With Prefrontal and Subcortical Dysfunction in Ultra High-Risk Individuals
- (2012) P. Allen et al. SCHIZOPHRENIA BULLETIN
- Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [18F]-DOPA PET Imaging Study
- (2011) Oliver D. Howes et al. AMERICAN JOURNAL OF PSYCHIATRY
- Imaging Changes in Glutamate Transmission In Vivo with the Metabotropic Glutamate Receptor 5 Tracer [11C] ABP688 and N-Acetylcysteine Challenge
- (2011) Nobumi Miyake et al. BIOLOGICAL PSYCHIATRY
- Grey matter and social functioning correlates of glutamatergic metabolite loss in schizophrenia
- (2011) Naoko Aoyama et al. BRITISH JOURNAL OF PSYCHIATRY
- Cost of disorders of the brain in Europe 2010
- (2011) Anders Gustavsson et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Increased prefrontal cortical D1 receptors in drug naïve patients with schizophrenia: a PET study with [11C]NNC112
- (2011) Anissa Abi-Dargham et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study
- (2011) O Howes et al. MOLECULAR PSYCHIATRY
- Schizophrenia susceptibility pathway neuregulin 1–ErbB4 suppresses Src upregulation of NMDA receptors
- (2011) Graham M Pitcher et al. NATURE MEDICINE
- Higher Levels of Glutamate in the Associative-Striatum of Subjects with Prodromal Symptoms of Schizophrenia and Patients with First-Episode Psychosis
- (2011) Camilo de la Fuente-Sandoval et al. NEUROPSYCHOPHARMACOLOGY
- Abnormal Activity of the MAPK- and cAMP-Associated Signaling Pathways in Frontal Cortical Areas in Postmortem Brain in Schizophrenia
- (2011) Adam J Funk et al. NEUROPSYCHOPHARMACOLOGY
- In vivoandex vivoevidence for ketamine-induced hyperglutamatergic activity in the cerebral cortex of the rat: Potential relevance to schizophrenia
- (2011) Sang-Young Kim et al. NMR IN BIOMEDICINE
- Striatal dopamine synthesis capacity in twins discordant for schizophrenia
- (2011) P. Shotbolt et al. PSYCHOLOGICAL MEDICINE
- Abnormal Relationship Between Medial Temporal Lobe and Subcortical Dopamine Function in People With an Ultra High Risk for Psychosis
- (2011) P. Allen et al. SCHIZOPHRENIA BULLETIN
- Glutamate in Schizophrenia: A Focused Review and Meta-Analysis of 1H-MRS Studies
- (2011) Anouk Marsman et al. SCHIZOPHRENIA BULLETIN
- Striatal Dopamine Transporter Availability in Drug-Naive Patients With Schizophrenia: A Case-Control SPECT Study With [99mTc]-TRODAT-1 and a Meta-Analysis
- (2011) K. C. Chen et al. SCHIZOPHRENIA BULLETIN
- Dopamine agonist radioligand binds to both D2High and D2Low receptors, explaining why alterations in D2High are not detected in human brain scans
- (2011) Philip Seeman SYNAPSE
- Cognition in schizophrenia: core psychological and neural mechanisms
- (2011) Deanna M. Barch et al. TRENDS IN COGNITIVE SCIENCES
- Abnormal Frontostriatal Interactions in People With Prodromal Signs of Psychosis
- (2010) Paolo Fusar-Poli et al. ARCHIVES OF GENERAL PSYCHIATRY
- Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
- (2010) Lawrence S. Kegeles et al. ARCHIVES OF GENERAL PSYCHIATRY
- Altered Relationship Between Hippocampal Glutamate Levels and Striatal Dopamine Function in Subjects at Ultra High Risk of Psychosis
- (2010) James M. Stone et al. BIOLOGICAL PSYCHIATRY
- Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis
- (2010) Guochuan Tsai et al. CURRENT PHARMACEUTICAL DESIGN
- The Dopamine D1-D2 Receptor Heteromer Localizes in Dynorphin/Enkephalin Neurons
- (2010) Melissa L. Perreault et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Imaging Cortical Dopamine D1 Receptors Using [11C]NNC112 and Ketanserin Blockade of the 5-HT2A Receptors
- (2010) Ana M Catafau et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- The NADPH Oxidase NOX2 Controls Glutamate Release: A Novel Mechanism Involved in Psychosis-Like Ketamine Responses
- (2010) S. Sorce et al. JOURNAL OF NEUROSCIENCE
- Decreased binding of [11C]NNC112 and [11C]SCH23390 in patients with chronic schizophrenia
- (2010) Jun Kosaka et al. LIFE SCIENCES
- A Possible Role for the Striatum in the Pathogenesis of the Cognitive Symptoms of Schizophrenia
- (2010) Eleanor H. Simpson et al. NEURON
- Dopamine in Motivational Control: Rewarding, Aversive, and Alerting
- (2010) Ethan S. Bromberg-Martin et al. NEURON
- Dopaminergic Dysfunction in Schizophrenia: Salience Attribution Revisited
- (2010) A. Heinz et al. SCHIZOPHRENIA BULLETIN
- LY2140023 MONOHYDRATE: AN AGONIST AT THE MGLU2/3 RECEPTOR FOR THE TREATMENT OF SCHIZOPHRENIA
- (2010) Bruce J. Kinon et al. SCHIZOPHRENIA RESEARCH
- Schizophrenia, amphetamine-induced sensitized state and acute amphetamine exposure all show a common alteration: increased dopamine D2 receptor dimerization
- (2010) Min Wang et al. Molecular Brain
- Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
- (2009) Oliver D. Howes et al. ARCHIVES OF GENERAL PSYCHIATRY
- Reward Feedback Alterations in Unmedicated Schizophrenia Patients: Relevance for Delusions
- (2009) Florian Schlagenhauf et al. BIOLOGICAL PSYCHIATRY
- Glutamate Dysfunction in People with Prodromal Symptoms of Psychosis: Relationship to Gray Matter Volume
- (2009) James M. Stone et al. BIOLOGICAL PSYCHIATRY
- Baseline and Amphetamine-Stimulated Dopamine Activity Are Related in Drug-Naïve Schizophrenic Subjects
- (2009) Anissa Abi-Dargham et al. BIOLOGICAL PSYCHIATRY
- Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging
- (2009) O. Howes et al. CURRENT PHARMACEUTICAL DESIGN
- A Double-Blind, Randomized Study of Minocycline for the Treatment of Negative and Cognitive Symptoms in Early-Phase Schizophrenia
- (2009) Yechiel Levkovitz et al. JOURNAL OF CLINICAL PSYCHIATRY
- 1H-MRS at 4 Tesla in minimally treated early schizophrenia
- (2009) J R Bustillo et al. MOLECULAR PSYCHIATRY
- Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis
- (2009) P Fusar-Poli et al. MOLECULAR PSYCHIATRY
- The test–retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function
- (2009) Alice Egerton et al. NEUROIMAGE
- Decreased expression of NMDA receptor-associated proteins in frontal cortex of elderly patients with schizophrenia
- (2009) Adam J. Funk et al. NEUROREPORT
- PET Studies of Cerebral Levodopa Metabolism: A Review of Clinical Findings and Modeling Approaches
- (2009) Yoshitaka Kumakura et al. NEUROSCIENTIST
- Creatine abnormalities in schizophrenia and bipolar disorder
- (2009) Dost Öngür et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
- (2009) O. D. Howes et al. SCHIZOPHRENIA BULLETIN
- The effect of ageing on grey and white matter reductions in schizophrenia
- (2009) Subrata K. Bose et al. SCHIZOPHRENIA RESEARCH
- Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: Investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus
- (2009) So Young Yoo et al. SCHIZOPHRENIA RESEARCH
- Striatal metabolic alterations in non-psychotic adolescent offspring at risk for schizophrenia: A 1H spectroscopy study
- (2009) Matcheri S. Keshavan et al. SCHIZOPHRENIA RESEARCH
- The efficacy of lamotrigine in clozapine-resistant schizophrenia: A systematic review and meta-analysis
- (2009) Jari Tiihonen et al. SCHIZOPHRENIA RESEARCH
- Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: A comparative evaluation of the high affinity dopamine D2/3radiotracers [11C]FLB 457 and [11C]fallypride
- (2009) Rajesh Narendran et al. SYNAPSE
- In vivo [123I]CNS-1261 binding to D-serine-activated and MK801-blocked NMDA receptors: A storage phosphor imaging study in rats
- (2009) Remco J.J. Knol et al. SYNAPSE
- Further evaluation of the carbon11-labeled D2/3agonist PET radiotracer PHNO: Reproducibility in tracer characteristics and characterization of extrastriatal binding
- (2009) Alice Egerton et al. SYNAPSE
- Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls
- (2008) Celia J. A. Morgan et al. ADDICTION
- Glutamate and the Neural Basis of the Subjective Effects of Ketamine
- (2008) J. F. William Deakin et al. ARCHIVES OF GENERAL PSYCHIATRY
- ‘Truman’ signs and vulnerability to psychosis
- (2008) Paolo Fusar-Poli et al. BRITISH JOURNAL OF PSYCHIATRY
- Minocycline as Adjunctive Therapy for Schizophrenia
- (2008) Tsuyoshi Miyaoka et al. CLINICAL NEUROPHARMACOLOGY
- Proton MRS in twin pairs discordant for schizophrenia
- (2008) E S Lutkenhoff et al. MOLECULAR PSYCHIATRY
- The Dopamine D2 Receptors in High-Affinity State and D3 Receptors in Schizophrenia: A Clinical [11C]-(+)-PHNO PET Study
- (2008) Ariel Graff-Guerrero et al. NEUROPSYCHOPHARMACOLOGY
- White Matter Alterations in Deficit Schizophrenia
- (2008) Laura M Rowland et al. NEUROPSYCHOPHARMACOLOGY
- Do patients with schizophrenia exhibit aberrant salience?
- (2008) J. P. Roiser et al. PSYCHOLOGICAL MEDICINE
- Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats
- (2008) Alice Egerton et al. PSYCHOPHARMACOLOGY
- Psychiatric Comorbidities and Schizophrenia
- (2008) P. F. Buckley et al. SCHIZOPHRENIA BULLETIN
- Elevated 3T proton MRS glutamate levels associated with poor Continuous Performance Test (CPT-0X) scores and genetic risk for schizophrenia
- (2008) Scot E. Purdon et al. SCHIZOPHRENIA RESEARCH
- Regional dopamine synthesis in patients with schizophrenia using L-[β-11C]DOPA PET
- (2008) Shoko Nozaki et al. SCHIZOPHRENIA RESEARCH
- Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS)
- (2008) Shin'Ya Tayoshi et al. SCHIZOPHRENIA RESEARCH
- Functional neuroimaging in schizophrenia: diagnosis and drug discovery
- (2008) P MCGUIRE et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Frontolimbic glutamate alterations in first episode schizophrenia: Evidence from a magnetic resonance spectroscopy study
- (2008) Hans M. Olbrich et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Striatal Dopamine Synthesis in First-degree Relatives of Patients with Schizophrenia
- (2007) Jukka Huttunen et al. BIOLOGICAL PSYCHIATRY
- Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline
- (2007) Yuko Fujita et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started